Nezam El-Tayebat 事实核查对“نظام الطيبات”饮食体系的科学评估
选择国家
选择语言: 简体中文

基本错误 过度解读 证据确定性: 高 初步 C-INS-09

葡萄糖进入细胞并不需要胰岛素（红细胞内的糖化血红蛋白HbA1c就证明了这一点）；因此，胰岛素并不能治疗糖尿病，反而会让细胞、尤其是大脑“饿”着得不到糖。

安全提示: 请不要因为这一说法而停用或减少胰岛素。在1型糖尿病和其他胰岛素缺乏的情况下，停用胰岛素会在数小时至数天内导致糖尿病酮症酸中毒，这会危及生命。医学界公认的立场（ADA Standards of Care 2026）：胰岛素治疗对1型糖尿病患者是必不可少的；接受强化胰岛素治疗的人即使不进食，也不应停用基础胰岛素。糖尿病药物的任何调整都应与主治医生共同进行。
简而言之: 该说法基本错误。大脑和红细胞摄取葡萄糖确实不需要胰岛素，但肌肉和脂肪需要胰岛素，而且胰岛素能阻止肝脏释放葡萄糖和酮体；胰岛素治疗能减少并发症并降低长期死亡率，只有胰岛素过量才会使大脑缺乏葡萄糖。
结论: 有些细胞摄取葡萄糖不需要胰岛素，但这并不意味着胰岛素治疗无用或有害。
  1. 原始表述
  2. 科学评估
  3. 科学证据详解
  4. 通俗解释
  5. 与该说法相关的研究
  6. 地区背景
  7. 在我的国家适用什么？
  8. 参考文献

原始表述

الانسولين ضروري لدخول السكر سكر في الخلايا غلط والدليل ان التراكمي جوه الخليه

按来源为原话. 译文由本项目提供；以阿拉伯语原文为准。

译文

葡萄糖进入细胞并不需要胰岛素（红细胞内的糖化血红蛋白HbA1c就证明了这一点）；因此，胰岛素并不能治疗糖尿病，反而会让细胞、尤其是大脑“饿”着得不到糖。

出处

来源状态
视频转录文本（本人原话）
归属
Elawady (machine transcript)
视频
Dr Diaa Al Awady د ضياء العوضي is live! لايف منتظر (打开来源)
发布日期
2026年2月8日
时间戳
0:15:57 (在原视频 YouTube 自动字幕轨中的位置；可确认该内容出现的位置，但不能确认说话人是谁)
归属的不确定性
Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
所声称的机制

Glucose enters red blood cells and brain cells without insulin; insulin pushes glucose into storage and away from the brain.

所声称的健康影响

Insulin starves cells; insulin is useless as therapy

涉及人群

People with diabetes

Elawady 设定的地域限制

none found

来源版本存在差异

来源状态
视频转录文本（本人原话）
归属
Elawady (machine transcript)
视频
ارتفاع السكر والأسيتون ؟خطر والا ده الطبيعي ؟#ضياء_العوضي (打开来源)
发布日期
2025年12月23日
时间戳
无（转录文本不含时间信息）
归属的不确定性
Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
来源状态
视频转录文本（本人原话）
归属
Elawady (machine transcript)
视频
المفاهيم المضللة عن الإنسولين ومغالطات شائعه حول الإنسولين #ضياء_العوضي (打开来源)
发布日期
2026年4月17日
时间戳
无（转录文本不含时间信息）
归属的不确定性
Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.

科学评估

基本错误 – 该说法的主要部分没有证据支持，或被严重夸大。

证据确定性: 高 – 进一步研究极不可能改变该评估。

1. 说法是什么？

Insulin is not needed for glucose uptake, so it does not treat anything and starves cells.

2. 哪些内容可证实是正确的？

Glucose uptake into red blood cells and brain does not require insulin; glycated haemoglobin forms inside red cells without insulin. Too much insulin causes hypoglycaemia, which deprives the brain of glucose (A-INS-14, A-INS-15).

3. 哪些内容是错误或夸大的？

Muscle (the largest glucose sink after meals) and fat tissue need insulin for glucose uptake; the liver needs insulin signals to stop releasing glucose and producing ketones. That is why absolute insulin deficiency (type 1 diabetes) causes high glucose, ketoacidosis and weight loss despite eating. HbA1c is a valid measure of average glucose exposure and predicts complications (I-INS-04). Insulin therapy lowers glucose and complications in RCTs (I-INS-03, A-INS-16). The claim that 'no drug on earth lowers sugar' is contradicted by every glucose-lowering trial cited by the archive itself.

4. 哪些内容仍不明确？

When insulin 'does not work' in practice, causes such as injection into lipohypertrophic tissue (blunted and variable absorption, A-INS-20), insulin resistance or omitted doses should be considered; they do not show that insulin is ineffective.

5. 哪些研究支持该说法？

Physiology of insulin-independent glucose transporters (kernel only).

6. 哪些研究与该说法相矛盾？

I-INS-03, I-INS-04, A-INS-16, I-INS-07, I-INS-104 (intensive insulin therapy associated with lower long-term mortality), I-INS-116 (insulin withdrawal lowers muscle ATP production and raises ketones), I-INS-133, I-INTB-01.

7. 对德国和欧洲而言情况如何？

European (EASD) and German (DDG) guidance follow the same evidence base as the ADA/EASD consensus: individualised HbA1c targets, insulin as mandatory therapy in type 1 diabetes, and SGLT2 inhibitors/GLP-1 receptor agonists for people with cardiovascular or kidney disease. No country-specific difference changes the assessment.

8. 关于埃及的已知情况是什么？

Egypt has one of the highest diabetes prevalences in the region; the same drug classes and insulins are used. Access barriers and cost may make advice to stop medication attractive, which increases the practical risk of this claim. No Egypt-specific evidence changes the assessment.

9. 合理的实际结论是什么？

有些细胞摄取葡萄糖不需要胰岛素，这一事实并不意味着胰岛素是不必要的；需要胰岛素的人必须继续使用。

评估详情

证据确定性的依据

Correct kernel: red blood cells, brain and liver take up glucose largely independent of insulin (GLUT1/GLUT3/GLUT2), and HbA1c forms inside red cells without insulin. Wrong conclusion: skeletal muscle and fat depend on insulin (GLUT4); insulin also suppresses liver glucose and ketone production; insulin deficiency leads to ketoacidosis and death (type 1 diabetes). Insulin's efficacy is shown in RCTs (DCCT, UKPDS).

来源质量

Own words, several machine transcripts.

地区可推广性

Universal.

说法的地域范围
普遍性（生物学/医学）
最近审核
2026年10月26日 初步

科学证据详解

过度解读 – 确有真实的发现，但该说法从中引申出的结论超出了数据所能支持的范围（例如把关联当作因果、把动物数据套用到人身上、把小效应说成大效应）。

研究问题: Is insulin unnecessary for glucose uptake, so that insulin therapy does not treat diabetes but starves cells?

研究问题详解 (PECO)
人群
People with diabetes
干预或暴露
Insulin action/therapy
对照
Insulin deficiency
地域范围
universal biology
结局指标
  • Glucose uptake by tissues
  • Ketosis
  • Clinical outcomes of insulin therapy

研究结果按作者报告呈现。我们的评估见下文。

哪些证据支持该说法？

  • Severe low blood sugar and death in ACCORD

    Bonds DE et al.. BMJ 2010 · PMID 20061358 · DOI 10.1136/bmj.b4909 队列研究全文，含结构化偏倚风险评估

    Severe hypoglycaemia from glucose-lowering therapy is associated with mortality.

    实际结果
    aHR 1.41-2.30.
    方法学质量
    moderate
    相关性
    indirect: excess insulin can deprive the brain of glucose
    局限
    Concerns overdosing, not normal therapy.

    原始文献

哪些证据不支持该说法？

总体证据说明了什么？

基于上述研究的编辑评估——其本身并非研究结果。

哪种观点有更好的证据支持？

Some tissues (brain, red cells) take up glucose without insulin, but muscle and fat need insulin, and insulin suppresses hepatic glucose and ketone output; insulin therapy lowers complications and mortality.

为什么有些研究权重更大

RCTs and physiology outweigh the correct but misapplied kernel.

因果关系是否已确立？ 是，已确立 Insulin deficiency causes hyperglycaemia and ketoacidosis; insulin reverses them.

仍存在的不确定性

None material.

合理的结论

Mostly false: true kernel, wrong conclusion.

这是否取决于国家？
一般生物学效应
Insulin physiology, autoimmune type 1 diabetes and ketoacidosis are universal human biology.
饮食习惯
Egyptian and European diets differ, but no dietary pattern replaces insulin in insulin-deficient diabetes.
食品原产地
Not relevant.
污染物
Not relevant.
本国生产条件
Not relevant.
法律规则
Insulin is an essential medicine (WHO list) in Egypt and the EU; prescription rules not relevant to the scientific question.
实际监测数据
Egyptian/Middle Eastern data show severe DKA is common at presentation in children (I-INS-115, I-INS-114); no data on outcomes among Tayebat followers.

足以改变结论的地区差异没有可靠数据支持。

统计复核
  • Crude mortality by arm – 6.0% vs 8.8% 已重新计算
总体证据的确定性（GRADE，简化版）
主要结局
Clinical efficacy of insulin therapy in insulin-deficient diabetes
起始等级
高（随机试验）
结果
高

由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。

已核查的临床指南和官方声明
  • ADA/EASD: The management of type 1 diabetes in adults: updated 2026 consensus report (2026) · 原始文献
    'Lifelong insulin therapy is essential in type 1 diabetes'; all individuals need glucose and ketone testing supplies; insulin omission or under-dosing is a DKA precipitant.
  • ADA: 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (I-ODD-16) (2026) · 原始文献
    'Insulin treatment is essential for individuals with type 1 diabetes'; insulin to be considered in T2D when A1C >10%, glucose >=300 mg/dL or catabolic features (as recorded for I-ODD-16).
  • ADA: 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026) · 原始文献
    People at risk for DKA should have ketone testing tools and sick-day advice; people on intensive insulin therapy should not stop or hold basal insulin even if not eating; caution with near-normal A1C goals in long-standing T2D using hypoglycaemia-prone drugs (ACCORD).
检索策略

本次审查的文献检索记录（检索式采用原数据库语法）。

数据库日期检索式检索目标命中数纳入数
PubMed2026年10月26日(brain glucose uptake OR cerebral glucose metabolism) AND (insulin-independent OR "independent of insulin") AND human支持性证据513
Europe PMC2026年10月26日(TITLE:"red blood cell" OR TITLE:"erythrocyte") AND (TITLE:"glucose uptake" OR TITLE:"GLUT1") AND insulin支持性证据4
Europe PMC2026年10月26日(TITLE:"insulin") AND (TITLE:"brain" OR TITLE:"cerebral") AND (TITLE:"glucose uptake") AND human支持性证据8
PubMed2026年10月26日DeFronzo RA[au] AND "disposal of intravenous glucose"反对性证据19
PubMed2026年10月26日(GLUT4 OR "skeletal muscle") AND "insulin-stimulated glucose uptake" AND human AND review[pt]反对性证据80
PubMed2026年10月26日"insulin deprivation" AND mitochondrial AND ATP AND "type 1 diabetes"反对性证据2
PubMed2026年10月26日DCCT EDIC AND mortality AND JAMA[ta] AND 2015[dp]反对性证据1

核查深度如何？

11 项相关研究：4 项核查了全文（其中 2 项进行了结构化偏倚风险评估），7 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。

最近一次科学审核: 2026年10月26日

评定结论的变更历史
  1. 2026年10月25日 · 第 1 阶段 · 初始评估: 基本错误 (高)
  2. 2026年10月26日 · 第 4 阶段（系统证据审查） · 在扩展证据后重新审查；评定结论不变: 基本错误 (高)
    New evidence (DCCT/EDIC mortality, insulin-withdrawal physiology) strengthens the existing assessment; the insulin-independent glucose uptake kernel remains correct.
    新来源: I-INS-104 I-INS-116 I-INS-133

通俗解释

大脑和红细胞摄取糖分确实不需要胰岛素。但肌肉和脂肪组织需要胰岛素，胰岛素还会告诉肝脏停止向血液中大量释放糖和酸性物质。不能产生胰岛素的人即使大脑能摄取糖分，也会病得很重。试验已证明，胰岛素治疗能降低血糖并预防并发症。

与该说法相关的研究

支持该说法的研究 (0)

该组中没有研究。

与该说法相矛盾或限制该说法的研究 (8)

  • DCCT: better insulin treatment in type 1 diabetes

    Diabetes Control and Complications Trial Research Group; Nathan DM et al.. N Engl J Med 1993 · PMID 8366922 · DOI 10.1056/NEJM199309303291401
    随机对照试验独立交叉核查已核查摘要★ 关键研究

    Intensive insulin cut the risk of eye damage by three-quarters and nerve damage by 60%, with more low-sugar episodes.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Does intensive insulin therapy reduce long-term complications in type 1 diabetes?

    研究是如何开展的？

    Multicentre RCT (DCCT)

    研究了多少人、动物或样本？

    1,441; Insulin-dependent (type 1) diabetes

    实际发现了什么？

    Large reductions in all microvascular complications.

    观察到的效应有多大？

    Retinopathy -76%

    研究结果对日常生活意味着什么？

    Insulin protects eyes, kidneys and nerves in type 1 diabetes.

    该研究有哪些局限？

    Open-label; Selected young population

    它对 Elawady 的具体说法说明了什么？

    Contradicts C-INS-07, C-INS-09, C-DIAB-01; shows insulin efficacy and hypoglycaemia cost (C-INS-02 kernel).

    研究结果是否适用于德国和欧洲？

    North American; universally accepted.

    从该研究中明确不能得出什么结论？

    Effects in type 2 diabetes directly.

    科学细节 →

  • How much long-term blood sugar matters (UKPDS 35)

    Stratton IM et al.. BMJ 2000 · PMID 10938048 · DOI 10.1136/bmj.321.7258.405
    队列研究独立交叉核查已核查摘要★ 关键研究

    Each 1% lower HbA1c was linked to 21% fewer diabetes deaths and 37% fewer eye/kidney complications.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Relation of glycaemia over time to complications

    研究是如何开展的？

    Prospective observational analysis within UKPDS (UKPDS 35)

    研究了多少人、动物或样本？

    4,585 (3,642 for RR); UKPDS patients (white, Asian Indian, Afro-Caribbean)

    实际发现了什么？

    Graded risk with HbA1c, no threshold.

    观察到的效应有多大？

    -21% per 1% HbA1c

    研究结果对日常生活意味着什么？

    High sugar damages the body.

    该研究有哪些局限？

    Observational

    它对 Elawady 的具体说法说明了什么？

    Contradicts C-DIAB-01, C-DIAB-02, C-ODD-06 (hyperglycaemia causes complications incl. amputation).

    研究结果是否适用于德国和欧洲？

    UK.

    从该研究中明确不能得出什么结论？

    That pushing HbA1c to normal is always safe.

    科学细节 →

  • UKPDS: tablets or insulin for new type 2 diabetes

    UKPDS Group. Lancet 1998 · PMID 9742976
    随机对照试验被 Tayebat 档案网站引用已核查摘要★ 关键研究

    Better sugar control with tablets or insulin cut eye/kidney complications by a quarter; insulin caused more weight gain and low-sugar episodes.

    该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Intensive control with sulfonylurea or insulin vs diet on complications

    研究是如何开展的？

    Multicentre RCT (UKPDS 33)

    研究了多少人、动物或样本？

    3,867; Newly diagnosed type 2 diabetes, median age 54

    实际发现了什么？

    Microvascular -25%; more hypoglycaemia and weight gain with insulin.

    观察到的效应有多大？

    RR reduction 25% microvascular

    研究结果对日常生活意味着什么？

    Insulin helps prevent complications but has side effects.

    该研究有哪些局限？

    Open-label; Older drug regimens

    它对 Elawady 的具体说法说明了什么？

    Supports weight/hypoglycaemia (C-INS-01); contradicts C-INS-03, C-INS-05, C-DIAB-01.

    研究结果是否适用于德国和欧洲？

    UK; directly relevant.

    从该研究中明确不能得出什么结论？

    That insulin is harmful overall.

    科学细节 →

  • International guideline on diabetic ketoacidosis

    Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    Insulin, fluids and potassium are the core treatment; with this, fewer than 1% of adults die.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Diagnosis and management of DKA and HHS in adults

    研究是如何开展的？

    International consensus report based on systematic examination of literature since 2009 (ADA, EASD, JBDS, AACE, DTS)

    研究了多少人、动物或样本？

    not applicable; Adults with diabetes

    实际发现了什么？

    Insulin is the cornerstone; glucocorticoids worsen hyperglycaemia.

    观察到的效应有多大？

    Mortality <1% with treatment

    研究结果对日常生活意味着什么？

    Ketoacidosis needs hospital treatment with insulin.

    该研究有哪些局限？

    Consensus, not trial

    它对 Elawady 的具体说法说明了什么？

    Directly contradicts C-INS-08; supports danger in C-FAST-03; contradicts C-INS-07, C-INS-10.

    研究结果是否适用于德国和欧洲？

    EASD and JBDS (UK) co-authored; directly applicable.

    从该研究中明确不能得出什么结论？

    Outcomes of untreated DKA quantitatively.

    科学细节 →

  • Review: how insulin works and how insulin resistance arises

    Petersen MC, Shulman GI. Physiol Rev 2018 · PMID 30067154 · DOI 10.1152/physrev.00063.2017
    叙述性综述独立交叉核查已核查摘要

    Insulin resistance in muscle, liver and fat is a central process in type 2 diabetes; some mechanisms are still debated.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Summarise insulin action and resistance

    研究是如何开展的？

    Narrative review

    研究了多少人、动物或样本？

    Literature

    实际发现了什么？

    Insulin resistance is a key process in type 2 diabetes

    观察到的效应有多大？

    not applicable

    研究结果对日常生活意味着什么？

    Doctors and scientists treat insulin resistance as a real, measurable state.

    该研究有哪些局限？

    Narrative; abstract only

    它对 Elawady 的具体说法说明了什么？

    Contradicts 'there is no such thing as insulin resistance'.

    研究结果是否适用于德国和欧洲？

    Universal physiology

    从该研究中明确不能得出什么结论？

    Does not settle which mediator causes insulin resistance.

    科学细节 →

  • What happens to muscle energy when insulin is withheld in type 1 diabetes

    Karakelides H et al.. Diabetes 2007 · PMID 17660267 · DOI 10.2337/db07-0378
    其他独立交叉核查已核查摘要★ 关键研究

    Stopping insulin for about 9 hours reduced the muscle cells' energy (ATP) production and raised ketones and protein breakdown.

    Without insulin, muscle energy production falls and ketones rise.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Test how insulin lack affects muscle energy production.

    研究是如何开展的？

    Insulin withdrawal vs insulin, muscle biopsies.

    研究了多少人、动物或样本？

    9 adults with T1D.

    实际发现了什么？

    Less mitochondrial ATP production, more ketones and protein loss without insulin.

    观察到的效应有多大？

    Not given in abstract.

    研究结果对日常生活意味着什么？

    Insulin keeps the cell's energy engine running; lack of insulin slows it.

    该研究有哪些局限？

    Very small study.

    它对 Elawady 的具体说法说明了什么？

    Contradicts 'insulin stops the Krebs cycle'.

    研究结果是否适用于德国和欧洲？

    Universal physiology.

    从该研究中明确不能得出什么结论？

    Cannot quantify long-term effects.

    科学细节 →

  • Long-term survival after intensive insulin treatment in type 1 diabetes

    Writing Group for the DCCT/EDIC Research Group et al.. JAMA 2015 · PMID 25562265 · DOI 10.1001/jama.2014.16107
    随机对照试验独立交叉核查已核查摘要★ 关键研究

    People who received intensive insulin treatment for about 6.5 years had about one third lower death risk 27 years later.

    Intensive insulin therapy associated with lower mortality: insulin does treat diabetes.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Test whether intensive insulin therapy affects long-term survival.

    研究是如何开展的？

    Follow-up of a randomised trial.

    研究了多少人、动物或样本？

    1,441 young adults with T1D.

    实际发现了什么？

    43 vs 64 deaths; HR 0.67.

    观察到的效应有多大？

    -109 deaths per 100,000 patient-years.

    研究结果对日常生活意味着什么？

    Good insulin treatment helps people with type 1 diabetes live longer.

    该研究有哪些局限？

    Few deaths; later years observational.

    它对 Elawady 的具体说法说明了什么？

    Contradicts 'insulin does not treat diabetes'.

    研究结果是否适用于德国和欧洲？

    Applicable to Europe.

    从该研究中明确不能得出什么结论？

    Cannot separate effects of later care.

    科学细节 →

  • European and US consensus 2026 on type 1 diabetes in adults

    Holt RIG et al.. Diabetologia 2026 · PMID 42747450 · DOI 10.1007/s00125-026-06833-z
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    Lifelong insulin is essential in type 1 diabetes, and everyone with type 1 diabetes should be able to test glucose and ketones.

    Insulin is the essential treatment; ketosis without insulin leads to DKA.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Update guidance on adult T1D care.

    研究是如何开展的？

    Consensus report.

    研究了多少人、动物或样本？

    Not applicable.

    实际发现了什么？

    Insulin lifelong and essential; ketone testing for all.

    观察到的效应有多大？

    Not applicable.

    研究结果对日常生活意味着什么？

    People with type 1 diabetes must never stop insulin.

    该研究有哪些局限？

    Consensus.

    它对 Elawady 的具体说法说明了什么？

    Contradicts C-INS-07/09/10; supports C-INS-11.

    研究结果是否适用于德国和欧洲？

    European (EASD) guidance.

    从该研究中明确不能得出什么结论？

    Not applicable.

    科学细节 →

结果不一或不明确的研究 (3)

  • Severe low blood sugar and death in ACCORD

    Bonds DE et al.. BMJ 2010 · PMID 20061358 · DOI 10.1136/bmj.b4909
    队列研究被 Tayebat 档案网站引用全文，含结构化偏倚风险评估★ 关键研究

    People who had severe low-sugar episodes died more often, but this did not explain why the intensive group had more deaths.

    该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Link between severe hypoglycaemia and mortality in ACCORD

    研究是如何开展的？

    Retrospective epidemiological analysis within an RCT (ACCORD)

    研究了多少人、动物或样本？

    10,194; ACCORD participants with hypoglycaemia assessment

    实际发现了什么？

    Deaths were more common after severe low-sugar episodes (adjusted HR 1.41 and 2.30), but only 1 of 451 deaths was definitely caused by low sugar, and it explained only about 5 of 57 extra deaths in the intensive group.

    观察到的效应有多大？

    aHR 1.41 (1.03-1.93) intensive arm

    研究结果对日常生活意味着什么？

    Severe hypoglycaemia is a danger sign to avoid.

    该研究有哪些局限？

    Post-hoc observational analysis; Confounding by frailty

    它对 Elawady 的具体说法说明了什么？

    Supports C-INS-04 (hypoglycaemia is a marker of risk); limits causal interpretation.

    研究结果是否适用于德国和欧洲？

    Multinational/US/UK/European data; directly transferable to Germany/EU clinical practice.

    从该研究中明确不能得出什么结论？

    That hypoglycaemia caused the ACCORD excess mortality.

    科学细节 →

  • Severe hypoglycaemia in ADVANCE

    Zoungas S et al.. N Engl J Med 2010 · PMID 20925543 · DOI 10.1056/NEJMoa1003795
    队列研究被 Tayebat 档案网站引用全文，含结构化偏倚风险评估

    Severe low-sugar episodes were followed by more heart events and deaths, probably partly because frail people get them.

    该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Severe hypoglycaemia and vascular events/death

    研究是如何开展的？

    Post-hoc cohort analysis of an RCT (ADVANCE)

    研究了多少人、动物或样本？

    11,140; ADVANCE participants with type 2 diabetes

    实际发现了什么？

    aHR 2.69 death.

    观察到的效应有多大？

    aHR 2.69 (1.97-3.67)

    研究结果对日常生活意味着什么？

    Avoid severe hypoglycaemia.

    该研究有哪些局限？

    Only 231 people had severe hypoglycaemia; links also seen with skin and digestive disease (suggesting frailty); no dose-response; intensive treatment was a sulfonylurea, not insulin; funded by the drug's manufacturer.

    它对 Elawady 的具体说法说明了什么？

    Supports C-INS-04; kernel of C-INS-02.

    研究结果是否适用于德国和欧洲？

    Multinational/US/UK/European data; directly transferable to Germany/EU clinical practice.

    从该研究中明确不能得出什么结论？

    Causation.

    科学细节 →

  • Injecting insulin into thickened fat

    Famulla S et al.. Diabetes Care 2016 · PMID 27411698 · DOI 10.2337/dc16-0610
    随机对照试验被 Tayebat 档案网站引用已核查摘要

    Insulin injected into lumpy fat tissue works less and less predictably.

    该研究是否支持这一具体说法？ 不明确 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Insulin absorption from lipohypertrophic tissue

    研究是如何开展的？

    Randomised crossover clamp and meal study

    研究了多少人、动物或样本？

    13; Type 1 diabetes with lipohypertrophy

    实际发现了什么？

    Blunted, variable absorption.

    观察到的效应有多大？

    Insulin AUC -21%

    研究结果对日常生活意味着什么？

    Rotate injection sites.

    该研究有哪些局限？

    Small n

    它对 Elawady 的具体说法说明了什么？

    Peripheral; shows correct injection technique matters.

    研究结果是否适用于德国和欧洲？

    German study.

    从该研究中明确不能得出什么结论？

    That insulin is harmful.

    科学细节 →

地区背景

德国 / 欧盟

European (EASD) and German (DDG) guidance follow the same evidence base as the ADA/EASD consensus: individualised HbA1c targets, insulin as mandatory therapy in type 1 diabetes, and SGLT2 inhibitors/GLP-1 receptor agonists for people with cardiovascular or kidney disease. No country-specific difference changes the assessment.

埃及

Egypt has one of the highest diabetes prevalences in the region; the same drug classes and insulins are used. Access barriers and cost may make advice to stop medication attractive, which increases the practical risk of this claim. No Egypt-specific evidence changes the assessment.

在我的国家适用什么？

一般科学评估

基本错误 有些细胞摄取葡萄糖不需要胰岛素，但这并不意味着胰岛素治疗无用或有害。

该说法涉及生物学或医学关系。上述科学评估不论在哪个国家都适用；各国食品数据不会改变这一评估。

参考文献

  1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.. Diabetes Control and Complications Trial Research Group; Nathan DM et al.. N Engl J Med 1993 · PMID 8366922 · DOI 10.1056/NEJM199309303291401
  2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.. Stratton IM et al.. BMJ 2000 · PMID 10938048 · DOI 10.1136/bmj.321.7258.405
  3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.. UKPDS Group. Lancet 1998 · PMID 9742976
  4. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.. Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032
  5. Mechanisms of Insulin Action and Insulin Resistance.. Petersen MC, Shulman GI. Physiol Rev 2018 · PMID 30067154 · DOI 10.1152/physrev.00063.2017
  6. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects.. Karakelides H et al.. Diabetes 2007 · PMID 17660267 · DOI 10.2337/db07-0378
  7. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.. Writing Group for the DCCT/EDIC Research Group et al.. JAMA 2015 · PMID 25562265 · DOI 10.1001/jama.2014.16107
  8. The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).. Holt RIG et al.. Diabetologia 2026 · PMID 42747450 · DOI 10.1007/s00125-026-06833-z
  9. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.. Bonds DE et al.. BMJ 2010 · PMID 20061358 · DOI 10.1136/bmj.b4909
  10. Severe hypoglycemia and risks of vascular events and death.. Zoungas S et al.. N Engl J Med 2010 · PMID 20925543 · DOI 10.1056/NEJMoa1003795
  11. Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control.. Famulla S et al.. Diabetes Care 2016 · PMID 27411698 · DOI 10.2337/dc16-0610

← 返回概览